A V Efremov - JoVE Visualize

Showing results (31-40 of 35) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 35 results.

Terapevticheskii Arkhiv|June 20, 2015

[Assessment of the role of matrix metalloproteinase-3 gene polymorphism in the development of chronic heart failure]A T Teplyakov, E N Berezikova, S N Shilov, et al.

Bulletin of Experimental Biology and Medicine|January 16, 2009

Use of primary human fetal chondroblast culture for xenotransplantation into rat articular cartilage defectA V Sakharov, A A Makeyev, A V Efremov, et al.

Kardiologiia|April 4, 2013

[Pharmacogenomic control of angiotensin converting enzyme gene I/D polymorphism predominant risk factor of development of chronic heart failure and target of enalapril treatment]A T Tepliakov, S N Shilov, E N Berezikova, et al.

Terapevticheskii Arkhiv|April 27, 2011

[Impact of Gly389Arg beta1-adrenoceptor polymorphism on the risk of chronic heart failure, the nature of its course, and on the efficiency of its treatment with carvedilol]A T Tepliakov, S N Shilov, E N Berezikova, et al.

Terapevticheskii Arkhiv|October 14, 2016

[Role of soluble Fas ligand in myocardial remodeling, severity and outcomes of chronic heart failure]A T Teplyakov, E N Berezikova, S N Shilov, et al.

Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 35 results.

Terapevticheskii Arkhiv|June 20, 2015

[Assessment of the role of matrix metalloproteinase-3 gene polymorphism in the development of chronic heart failure]A T Teplyakov, E N Berezikova, S N Shilov, et al.

Bulletin of Experimental Biology and Medicine|January 16, 2009

Use of primary human fetal chondroblast culture for xenotransplantation into rat articular cartilage defectA V Sakharov, A A Makeyev, A V Efremov, et al.

Kardiologiia|April 4, 2013

[Pharmacogenomic control of angiotensin converting enzyme gene I/D polymorphism predominant risk factor of development of chronic heart failure and target of enalapril treatment]A T Tepliakov, S N Shilov, E N Berezikova, et al.

Terapevticheskii Arkhiv|April 27, 2011

[Impact of Gly389Arg beta1-adrenoceptor polymorphism on the risk of chronic heart failure, the nature of its course, and on the efficiency of its treatment with carvedilol]A T Tepliakov, S N Shilov, E N Berezikova, et al.

Terapevticheskii Arkhiv|October 14, 2016

[Role of soluble Fas ligand in myocardial remodeling, severity and outcomes of chronic heart failure]A T Teplyakov, E N Berezikova, S N Shilov, et al.

Pageof 4